Ra. Rossi et Nr. Every, A COMPUTERIZED INTERVENTION TO DECREASE THE USE OF CALCIUM-CHANNEL BLOCKERS IN HYPERTENSION, Journal of general internal medicine, 12(11), 1997, pp. 672-678
OBJECTIVE: To determine whether a computer-assisted reminder would alt
er prescribing habits for the treatment of hypertension in accordance
with current clinical guidelines in a general internal medicine clinic
. DESIGN:A randomized trial. SETTING: The General Internal Medicine Cl
inic of the Veterans Affairs Puget Sound Health Care System, Seattle D
ivision. PATIENTS/PARTICIPANTS: Clinic providers were randomized to a
control group (n = 35) or intervention group (n = 36). We targeted the
providers of patients being treated for hypertension with calcium cha
nnel blockers, a class of drug not recommended for initial therapy. IN
TERVENTION: An automated computer query identified eligible patients a
nd their providers, A guideline reminder was placed in the charts of p
atients of intervention providers; the charts of patients of control p
roviders received no reminder. MEASUREMENTS AND MAIN RESULTS: During t
he 5-month study period, 346 patients were seen by the 36 primary care
providers (staff physicians, nurse practitioners, residents, and fell
ows) in the intervention group, and 373 patients were seen by the 35 p
roviders in the control group, Intervention providers changed 39 patie
nts (11.3%) to other medications during the study period, compared wit
h 1 patient (<1.0%) of control providers (p < .0001). For patients who
se therapy was unchanged, providers noted angina in 23.1%, indications
other than those for hypertension in 9.5%, intolerable adverse effect
s with first-line therapy in 13.9%, and inadequate control with first-
line therapy in 13.9%. Of those patients without provider-indicated co
ntraindications, 23.6% were switched from calcium channel blockers to
first-line agents during the intervention period.CONCLUSIONS: The use
of a computerized, clinic-based intervention increased compliance with
guidelines in the treatment of primary hypertension in general, and d
ecreased the use of calcium channel blockers for the treatment of hype
rtension in particular.